Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 3Sanofi-Aventis Canada Inc.
02 1Blank
01 11312287
02 12117466
03 12151604
04 12152280
01 3Riluzole
02 1Blank
01 3Tablet
02 1Blank
01 12010-01-05
02 12012-10-22
03 12013-12-10
04 12014-01-03
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2013-12-10
Date Granted : 2005-09-20
Brand Name : RILUTEK
Patent Number : 2151604
Filing Date : 1993-12-10
Strength per Unit : 50mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2013-12-10
Date Granted : 2005-09-20
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2014-01-03
Date Granted : 2005-06-28
Brand Name : RILUTEK
Patent Number : 2152280
Filing Date : 1994-01-03
Strength per Unit : 50mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2014-01-03
Date Granted : 2005-06-28
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2012-10-22
Date Granted : 2000-01-25
Brand Name : RILUTEK
Patent Number : 2117466
Filing Date : 1992-10-22
Strength per Unit : 50mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-10-22
Date Granted : 2000-01-25
Patent Expiration Date : 2010-01-05
Date Granted :
Brand Name :
Patent Number : 1312287
Filing Date :
Strength per Unit :
Dosage Form :
Human Or VET :
Route of Administration :
Patent Expiration Date : 2010-01-05
Date Granted :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
